Pharmacy Articles

Pharmacy

sponsor

Your Unread Messages

Hello, Mary O'connor
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jensen A et al. – Ever use of any fertility drug was not associated with uterine cancer risk. However, ever use of gonadotropins (follicle–stimulating hormone and human menopausal gonadotropin) increased uterine cancer risk; the risk was primarily observed after 10 years of follow–up. Furthermore, uterine cancer risk increased with number of cycles of use for clomiphene and human chorionic gonadotropin but not for other gonadotropins. Use of gonadotropin–releasing hormone analogs was not associated with risk. Gonadotropins, and possibly clomiphene and human chorionic gonadotropin, may increase the risk of uterine cancer, with higher doses and longer follow–up leading to greater risk.

Related Articles

Use of Nonsteroidal Antiinflammatory Drugs and Risk of Endometrial Cancer
American Journal of Epidemiology, 11/09/09    Relevance Score: 79%

Effectiveness of cervical cancer screening at different ages
Women's Health, 10/30/09    Relevance Score: 77%

Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer
Cochrane Reviews, 10/09/09    Relevance Score: 77%

Dietary Sulforaphane, a Histone Deacetylase Inhibitor for Cancer Prevention
The Journal of Nutrition, 10/08/09    Relevance Score: 77%

Does screening history explain the ethnic differences in stage at diagnosis of cervical cancer in New Zealand?
International Journal of Epidemiology, 10/08/09    Relevance Score: 77%

Today in Adverse Drug Reactions...keeping you current

Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09

Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies
British Journal of Clinical Pharmacology, 11/24/09

Appraising the post-marketing safety of medicines: A description of national and international pharmacovigilance with a focus on medicines used in chronic pain
Current Anaesthesia and Critical Care, 11/24/09

Today in Other Drugs...keeping you current

Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
Diabetes Research and Clinical Practice, 11/24/09

Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09

DPP-4 Inhibitors in Clinical Practice
Postgraduate Medicine, 11/24/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address